Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Genetic Services Laboratory University of Chicago United States | 13 | 24 |
|
Tier 1 Panel: Diazoxide Unresponsive Hyperinsulinism Genetic Services Laboratory University of Chicago United States | 2 | 3 |
|
Department of Clinical Genetics Odense University Hospital Denmark | 2 | 1 |
|
GCK - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 173 | 119 |
|
Invitae Monogenic Diabetes Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 59 | 28 |
|
PreventionGenetics, part of Exact Sciences United States | 101 | 54 |
|
PreventionGenetics, part of Exact Sciences United States | 131 | 115 |
|
Maturity-Onset Diabetes of the Young (MODY) Panel Ambry Genetics United States | 14 | 5 |
|
Level 2: Expanded Congenital Hyperinsulinism Panel Genetic Diagnostic Laboratory University of Pennsylvania School of Medicine United States | 7 | 6 |
|
Level 1: Congenital Hyperinsulinisim Panel Genetic Diagnostic Laboratory University of Pennsylvania School of Medicine United States | 5 | 3 |
|
Congenital Hyperinsulinism Panel PreventionGenetics, part of Exact Sciences United States | 9 | 9 |
|
Hyperglycemia and Hypoglycemia via the GCK Gene PreventionGenetics, part of Exact Sciences United States | 3 | 1 |
|
Dyslipidemia and early atherosclerosis panel. 84-gene NGS panel. Genologica Medica Spain | 133 | 84 |
|
MODY type diabetes panel. NGS panel of 13 genes. Genologica Medica Spain | 29 | 13 |
|
Comprehensive panel of monogenic diabetes. 28-gene NGS panel. Genologica Medica Spain | 60 | 28 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.